Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 1/2 1

Status

Completed 8Unknown 7Recruiting 6Withdrawn 1Terminated 1

Sponsor Class

OTHER 7INDUSTRY 1

Study Type

Interventional 4Observational 3

Sponsor

Cancer Type

Genitourinary 7

Conditions

Breast Neoplasms 1476Neoplasms 999Colorectal Neoplasms 830Carcinoma, Non-Small-Cell Lung 724Carcinoma, Hepatocellular 683Stomach Neoplasms 647Lung Neoplasms 584Prostatic Neoplasms 543Pancreatic Neoplasms 456Rectal Neoplasms 338Uterine Cervical Neoplasms 303Colonic Neoplasms 295Neoplasm Metastasis 292Ovarian Neoplasms 285Esophageal Neoplasms 279Recurrence 278Leukemia, Myeloid, Acute 253Head and Neck Neoplasms 241Multiple Myeloma 232Brain Neoplasms 204Polycystic Ovary Syndrome 200Nasopharyngeal Carcinoma 198Melanoma 198Precursor Cell Lymphoblastic Leukemia-Lymphoma 195Urinary Bladder Neoplasms 193Lymphoma 178Liver Neoplasms 178Endometrial Neoplasms 159Motor Activity 147Lymphoma, Large B-Cell, Diffuse 141

Interventions

talazoparib 1gallium 68 PSMA-11 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Unknown × OTHER × Prostate Cancer Metastatic × Clear all
NCT06251492 2024-02-20

Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID)

Fudan University

Phase 2 Unknown
30 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT05627778 2022-11-28

68Ga-P15-041 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Prostate Bone Metastasis

Peking Union Medical College Hospital

Phase 1/2 Unknown
30 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT05530395 2022-09-14

BAseLine TEstosterone as a Prognostic and/or Predictive bioMARKer in mHSPC

University Hospital Virgen de las Nieves

Unknown
300 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT05078151 2021-10-14

iPROMET

Vall d'Hebron Institute of Oncology

Phase NA Unknown
69 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT04660617 2021-05-11

A Multi-omics Study of Metastatic Prostate Cancer (MOSMPCA)

West China Hospital

Unknown
100 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT04824937 2021-04-01

Telaglenastat + Talazoparib In Prostate Cancer

Massachusetts General Hospital

Phase 2 Unknown
30 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT03414437 2019-03-19

Post-eRADicAte

Carolina Research Professionals, LLC

Unknown
31 enrolled
Genitourinary

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡